Next Article in Journal
Obesity and Psychological Factors Associated with Weight Loss after Bariatric Surgery: A Longitudinal Study
Previous Article in Journal
Chokeberry (A. melanocarpa (Michx.) Elliott)—A Natural Product for Metabolic Disorders?
 
 
Article

Evaluating the Efficacy of Probiotics in IBS Treatment Using a Systematic Review of Clinical Trials and Multi-Criteria Decision Analysis

1
Consorzio Italbiotec, Piazza Della Trivulziana 4/A, 20126 Milano, Italy
2
Institute of Biomedical Technologies, National Research Council, Via Fratelli Cervi 93, 20054 Segrate, Italy
*
Author to whom correspondence should be addressed.
Academic Editor: Toshifumi Ohkusa
Nutrients 2022, 14(13), 2689; https://doi.org/10.3390/nu14132689
Received: 7 June 2022 / Revised: 22 June 2022 / Accepted: 23 June 2022 / Published: 28 June 2022
(This article belongs to the Section Prebiotics and Probiotics)
The evaluation of probiotics’ efficacy in treating irritable bowel syndrome is supported by an increasing number of clinical studies based on a heterogeneous approach of products tested and the patient cohort involved. Although the role of gut microbiota dysbiosis in IBS pathogenesis and the beneficial contribution of probiotics were demonstrated, a tool to discriminate symptom-specific strains and a personalised medicine protocol are still lacking. Thus, this study employs, for the first time, a method that combines the preferred reporting items for systematic reviews and meta-analysis and multi-criteria decision analysis methods in a structured decision-making tool to analyze the efficacy of probiotic mix, in order to identify the most effective formulation and to discriminate which probiotics are more efficient in treating different symptoms. The PRISMA methodology resulted in a qualitative and quantitative analysis of 104 clinical studies from 2011 to 2021, revealing a prevalence of Lactobacillus rhamnosus, Lactobacillus acidophilus, and Bifidobacterium animalis subsp. lactis. MCDA analysis showed that formulations based on Lactobacillus rhamnosus and Lactobacillus acidophilus have the highest efficacy, especially on quality of life, bloating, and abdominal pain. This methodological approach could become more specific by modelling clinical studies according to the age and gender of patients and probiotic strain. View Full-Text
Keywords: microbiota dysbiosis; probiotics; irritable bowel syndrome; nutraceuticals; clinical trials; selective efficacy; multi-criterial decision analysis; PRISMA microbiota dysbiosis; probiotics; irritable bowel syndrome; nutraceuticals; clinical trials; selective efficacy; multi-criterial decision analysis; PRISMA
Show Figures

Figure 1

MDPI and ACS Style

Ceccherini, C.; Daniotti, S.; Bearzi, C.; Re, I. Evaluating the Efficacy of Probiotics in IBS Treatment Using a Systematic Review of Clinical Trials and Multi-Criteria Decision Analysis. Nutrients 2022, 14, 2689. https://doi.org/10.3390/nu14132689

AMA Style

Ceccherini C, Daniotti S, Bearzi C, Re I. Evaluating the Efficacy of Probiotics in IBS Treatment Using a Systematic Review of Clinical Trials and Multi-Criteria Decision Analysis. Nutrients. 2022; 14(13):2689. https://doi.org/10.3390/nu14132689

Chicago/Turabian Style

Ceccherini, Cecilia, Sara Daniotti, Claudia Bearzi, and Ilaria Re. 2022. "Evaluating the Efficacy of Probiotics in IBS Treatment Using a Systematic Review of Clinical Trials and Multi-Criteria Decision Analysis" Nutrients 14, no. 13: 2689. https://doi.org/10.3390/nu14132689

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop